1. How can the access to postnatal including home-based health services affected by the pandemic be improved (eg, using telemedicine)?
|
0.90
|
2. In pregnant women with SARS-CoV-2 infection or COVID-19 disease, what are the risk (eg, co-morbidities, co-infection) and determinants (eg, malnutrition, body composition) of adverse maternal and perinatal outcomes (eg, maternal morbidity, stillbirth, etc.)?
|
0.89
|
3. How has the COVID-19 pandemic affected health-seeking behavior for antenatal care, childbirth, or postnatal care (eg, frequency of visits, birth at health facilities, family planning advice, etc.)?
|
0.88
|
4. How can the access to maternal and perinatal health services affected by the pandemic be improved? (eg, skilled delivery, telemedicine, use of point of care ultrasound)
|
0.87
|
5. Is the safety and efficacy of the SARS-CoV-2 vaccine different in pregnant women compared to non-pregnant women?
|
0.87
|
6. What are the effective drugs/procedures to manage women with COVID-19 disease in the 1st, 2nd, and 3rd trimester of pregnancy?
|
0.87
|
7. How can the provision of essential maternal and perinatal health commodities affected by the pandemic be improved?
|
0.86
|
8. In postpartum women with COVID-19, what are the risk and determinants of transmission of SARS-CoV-2 to the newborn by breastfeeding or breastmilk?
|
0.85
|
9. Are pregnant women with complications such as pregnancy-induced hypertension, pre-eclampsia, gestational diabetes, malnutrition, anemia, HIV-1, and malaria at increased risk of SARS-CoV-2 infection or COVID-19 disease compared to women with uncomplicated pregnancies?
|
0.85
|
10. What are the risk and determinants of severe disease or death in pregnant women with SARS-CoV-2 infection or COVID-19 disease (eg, sociodemographic, immunological/hormonal, microbiota, nutritional)? |
0.85 |